Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

This study is ongoing, but not recruiting participants.

Study NCT00040846 Information provided by Fred Hutchinson Cancer Research Center

First Received: July 8, 2002 Last Updated: August 15, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2013
Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)